Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|October 7, 2014
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductaseLorillee C Tallorin, Jacob D Durrant, Quynh G Nguyen, et al.
G3 (Bethesda, Md.)|July 2, 2020
MutantHuntWGS: A Pipeline for Identifying Saccharomyces cerevisiae MutationsMitchell A Ellison, Jennifer L Walker, Patrick J Ropp, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|February 11, 2024
Functional convergence in gastric lysozymes of foregut-fermenting rodents, ruminants, and primates is not attributed to convergent molecular evolutionNick Barts, Roshni H Bhatt, Chelsea Toner, et al.
ACS Central Science|March 4, 2020
Mesoscale All-Atom Influenza Virus Simulations Suggest New Substrate Binding MechanismJacob D Durrant, Sarah E Kochanek, Lorenzo Casalino, et al.
Chemical Biology & Drug Design|May 23, 2012
Novel cruzain inhibitors for the treatment of Chagas' diseaseKathleen E Rogers, Henrik Keränen, Jacob D Durrant, et al.
Chemical Biology & Drug Design|April 29, 2017
Documenting and harnessing the biological potential of molecules in Distributed Drug Discovery (D3) virtual catalogsMilata M Abraham, Ryan E Denton, Richard W Harper, et al.
Chemical Reviews|April 14, 2016
Emerging Computational Methods for the Rational Discovery of Allosteric DrugsJeffrey R Wagner, Christopher T Lee, Jacob D Durrant, et al.
Chemical Biology & Drug Design|April 11, 2012
The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sicknessAaron J Friedman, Jacob D Durrant, Levi C T Pierce, et al.
Chemical Biology & Drug Design|June 24, 2011
Non-bisphosphonate inhibitors of isoprenoid biosynthesis identified via computer-aided drug designJacob D Durrant, Rong Cao, Alemayehu A Gorfe, et al.
Pageof 9